Literature DB >> 27742459

Identifying Patients With Atrial Fibrillation in Administrative Data.

Karen Tu1, Robby Nieuwlaat2, Stephanie Y Cheng3, Laura Wing3, Noah Ivers4, Clare L Atzema5, Jeff S Healey6, Paul Dorian7.   

Abstract

BACKGROUND: Identifying patients with atrial fibrillation (AF) using administrative data is important for epidemiologic and outcomes research. Although administrative data cover large populations, it is necessary to assess their validity in identifying AF patients.
METHODS: We used Ontario family physician electronic medical records from the Electronic Medical Record Administrative data Linked Database (EMRALD) as a reference standard to assess the accuracy of administrative data algorithms in identifying patients with AF. From a random sample of 7500 adult patients, patients with AF as recorded in family physician records were identified.
RESULTS: The optimal algorithm consisted of any of: hospitalization or an emergency room code for AF or prescription for an AF-specific antiarrhythmic agent or billing code for cardioversion, or prescription for an anticoagulant that was accompanied by a physician billing code. for arrhythmia. The algorithm sensitivity was 80.7% (95% confidence interval [CI], 75.1-86.3), specificity 99.1% (95% CI, 98.9-99.3), positive predictive value 71.1% (95% CI, 65.1-77.1), and negative predictive value 99.5% (95% CI, 99.3-99.7). This algorithm, applied to the Ontario population, resulted in a calculated increase in AF prevalence from 1.68% to 2.36% over the years 2000-2014. Anticoagulation rates for AF patients increased from 53% in 2011 to 60% in 2014. Among AF patients receiving anticoagulants, novel oral anticoagulant utilization increased from < 5% in 2011 to > 50% in 2014.
CONCLUSIONS: Identifying patients with AF can be done using administrative data, and the algorithm can be used to assess trends in disease burden over time and patterns of care in large populations. Copyright Â
© 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27742459     DOI: 10.1016/j.cjca.2016.06.006

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  32 in total

1.  Do Diagnostic and Procedure Codes Within Population-Based, Administrative Datasets Accurately Identify Patients with Rectal Cancer?

Authors:  Reilly P Musselman; Tara Gomes; Deanna M Rothwell; Rebecca C Auer; Husein Moloo; Robin P Boushey; Carl van Walraven
Journal:  J Gastrointest Surg       Date:  2018-12-03       Impact factor: 3.452

2.  Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation.

Authors:  Clare L Atzema; Cynthia A Jackevicius; Alice Chong; Paul Dorian; Noah M Ivers; Ratika Parkash; Peter C Austin
Journal:  CMAJ       Date:  2019-12-09       Impact factor: 8.262

Review 3.  Left Atrial Appendage Closure Device With Delivery System: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-04

4.  Association of Neighborhood-Level Material Deprivation With Health Care Costs and Outcome After Stroke.

Authors:  Amy Y X Yu; Eric E Smith; Murray Krahn; Peter C Austin; Mohammed Rashid; Jiming Fang; Joan Porter; Manav V Vyas; Susan E Bronskill; Richard H Swartz; Moira K Kapral
Journal:  Neurology       Date:  2021-08-18       Impact factor: 11.800

5.  The association between asthma and perinatal mental illness: a population-based cohort study.

Authors:  Amira M Aker; Simone N Vigod; Cindy-Lee Dennis; Tyler Kaster; Hilary K Brown
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

6.  Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients.

Authors:  Mohammed Shurrab; Cynthia A Jackevicius; Peter C Austin; Karen Tu; Feng Qiu; Joseph Caswell; Faith Michael; Jason G Andrade; Dennis T Ko
Journal:  J Interv Card Electrophysiol       Date:  2022-09-23       Impact factor: 1.759

7.  Novel Method of Atrial Fibrillation Case Identification and Burden Estimation Using the MIMIC-III Electronic Health Data Set.

Authors:  Eric Y Ding; Daniella Albuquerque; Michael Winter; Sophia Binici; Jaclyn Piche; Syed Khairul Bashar; Ki Chon; Allan J Walkey; David D McManus
Journal:  J Intensive Care Med       Date:  2019-07-28       Impact factor: 3.510

8.  Prescribing of two potentially interacting cardiovascular medications in atrial fibrillation patients on direct oral anticoagulants.

Authors:  Mohammed Shurrab; Maria Koh; Cynthia A Jackevicius; Feng Qiu; Michael Conlon; Joseph Caswell; Karen Tu; Peter C Austin; Dennis T Ko
Journal:  Int J Cardiol Heart Vasc       Date:  2021-04-29

9.  Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population-Based Cohort Study.

Authors:  Husam Abdel-Qadir; Madison Gunn; Iliana C Lega; Andrea Pang; Peter C Austin; Sheldon M Singh; Cynthia A Jackevicius; Karen Tu; Paul Dorian; Douglas S Lee; Dennis T Ko
Journal:  J Am Heart Assoc       Date:  2022-02-08       Impact factor: 6.106

10.  Surveillance for Outcomes Selected as Atrial Fibrillation Quality Indicators in Canada: 10-Year Trends in Stroke, Major Bleeding, and Heart Failure.

Authors:  Stephen B Wilton; Padma Kaul; Sunjidatul Islam; Clare L Atzema; Jennifer Cruz; Kendra MacFarlane; Robert McKelvie; Stephanie Poon; Laurie Lambert; Kathy Rush; Marc Deyell; D George Wyse; Jafna L Cox; Allan Skanes; Roopinder K Sandhu
Journal:  CJC Open       Date:  2021-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.